7th ESC ORCHID Meeting in Madrid

July 21, 2015 - 11:31 am

ORCHID last Consortium meeting took place on 22 and June 23 at the headquarters of GSK’s Tres Cantos. At that meeting, researchers of the project participants discussed scientific and organizational topics and presented the latest results. The perspective within the global strategy against TB was summarized in the presentation of the TB Alliance, that was open to

6th ESC ORCHID meeting in Madrid

August 20, 2014 - 3:38 pm

The 6th ORCHID Executive Steering Committee meeting was held on 25th-26th June in Madrid. The Tres Cantos team hosted this event, where the last scientific advances and next steps of the projectwere discussed.  


August 11, 2014 - 3:10 pm

publishable summary ORCHID 2nd reporting period We have successfuly completed our second reporting period in January 2014. Please, click in the link above if you want to find out more about the scientific advances performed so far by the consortium, in the development of new drugs to treat MDR and XDR-TB.

5th ESC ORCHID meeting in Paris

December 12, 2013 - 12:42 pm

The 5th ORCHID Executive Steering Committee meeting was held on 19th-20th November in Paris. Our colleagues from University of Pierre and Marie Curie hosted this event, where the last scientific advances and next steps were discussed.

The ORCHID team joined the Researchers´ Night in Madrid

December 12, 2013 - 9:14 am

The Researchers´ Night is an event sponsored by the European Commission that takes place in several cities across Europe. Here, several public and private research institutions present their scientific and technological developments with the aim of bringing research and innovation closer to the broader public. The GSK ORCHID team joined the last Madrid Researchers´ Night

WHO Tuberculosis Global Facts 2012

August 24, 2012 - 7:15 pm

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.